A synthetic "poop" was developed by researchers at the University of Guelph in Canada that works to treat C. diff infections of the GI tract. Now that stool transplants are becoming commonplace in the treatment of C. diff infection, an artificial culture of normal flora of the GI tract has been developed that avoids potential problems of occult infections in the donor stool.
While this can be lifesaving, stool transplantation should not be considered the first treatment of choice, when it is very easy to use probiotics and nutrients that support more normal GI function. Nonetheless, it is time to take another look at the mainstream treatment of C. diff and other dysbiotic infections of the gut.
